After 48 weeks of WD, both the untreated control and the SP16 treated groups had one tumor-free animal and five tumor-bearing animals and the NAFLD-induced depletion of CD4+ T cells was independent of tumor burden (Figure S4). Here, CD4 is linked to metabolic dysfunction-associated steatotic liver disease.